The test is performed in less than an hour using a buccal cheek swab, and runs on Genedrive’s hand-held real-time PCR instrument.
Researchers use the CRISPR/Cas9 gene editing approach to limit herpesviruses replication.
In addition to the hepatitis C panel, the company offers a number of next-generation sequencing-based tests including one for colorectal cancer.
A German clinical lab found that the test, run on Hologic's Panther system, was slightly more sensitive than a Roche assay on the High Pure System.
Enzo's fiscal first quarter revenues grew 2 percent year over year to $25.2 million, driven by an 8 percent spike in clinical laboratory services.
Following a beta evaluation of the system, a virology lab in Sheffield, UK, ran a workflow assessment and found improvements with the system.
The tests are the first assays approved by the FDA to run on the firm's Cobas 6800 and Cobas 8800 systems.
The DxN Veris was recently launched as a CE-marked product with a menu of viral load tests, and will launch in a few years in the US with STD and HAI assays.
The new assay uses high-resolution melt curve analysis to detect variations in genes that lead some people to spontaneously clear hepatitis C viral infections.
The assays add to the test menu of Beckman Coulter's DxN Veris molecular diagnostics system.
In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.
Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.
Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.
In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.